CTNM
Contineum Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.26
−0.75%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-24.0%
Return on equity
-23.0%
Return on assets
-27.0%
Return on invested capital
0.00x
Asset turnover
-$53.0M
Cash from operations
$6.29
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026